Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1974 1
1975 1
1976 3
1977 5
1978 1
1979 5
1980 2
1981 6
1982 2
1983 9
1984 10
1985 7
1986 22
1987 21
1988 19
1989 18
1990 24
1991 19
1992 29
1993 35
1994 30
1995 26
1996 34
1997 48
1998 32
1999 55
2000 47
2001 55
2002 74
2003 58
2004 77
2005 77
2006 101
2007 102
2008 115
2009 142
2010 145
2011 144
2012 217
2013 251
2014 232
2015 223
2016 247
2017 286
2018 283
2019 324
2020 382
2021 148
Text availability
Article attribute
Article type
Publication date

Search Results

3,737 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results. The following terms were ignored: %, %, %, % The following terms were not found in PubMed: 22Hristov, 5BAuthor
Page 1
The EQ-5D and the EuroQol Group.
Lloyd A, Pickard AS. Lloyd A, et al. Value Health. 2019 Jan;22(1):21-22. doi: 10.1016/j.jval.2018.12.002. Value Health. 2019. PMID: 30661629 Free article. No abstract available.
Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke.
de Graaf JA, Kuijpers M, Visser-Meily J, Kappelle LJ, Post M. de Graaf JA, et al. Clin Rehabil. 2020 Apr;34(4):545-550. doi: 10.1177/0269215520907990. Epub 2020 Feb 19. Clin Rehabil. 2020. PMID: 32070131
Cognitive problems were reported by 199 (55%) patients three months post-stroke. Internal consistencies of the EQ-5D-5L and EQ-5D-5L+C were 0.75 and 0.77, respectively. Adding a cognitive domain resulted in a decrease of the ceiling effect from 22% to 14%. Bo …
Cognitive problems were reported by 199 (55%) patients three months post-stroke. Internal consistencies of the EQ-5D-5L and EQ-5D
EQ-5D: a plea for accurate nomenclature.
Brooks R, Boye KS, Slaap B. Brooks R, et al. J Patient Rep Outcomes. 2020 Jul 3;4(1):52. doi: 10.1186/s41687-020-00222-9. J Patient Rep Outcomes. 2020. PMID: 32620995 Free PMC article.
Since 2009, EQ-5D has been available in three versions: EQ-5D-3L, EQ-5D-5L, and EQ-5D-Y, where 3L stands for three levels, 5L for five levels, and Y for youth. ...Two surveys - of arthritis applications, and 82 recent publications - found a variety of …
Since 2009, EQ-5D has been available in three versions: EQ-5D-3L, EQ-5D-5L, and EQ-5D-Y, where 3L stands for thr …
EQ-5D-5L population norms and health inequalities for Trinidad and Tobago.
Bailey H, Janssen MF, La Foucade A, Kind P. Bailey H, et al. PLoS One. 2019 Apr 29;14(4):e0214283. doi: 10.1371/journal.pone.0214283. eCollection 2019. PLoS One. 2019. PMID: 31034491 Free PMC article.
The 10 most commonly observed EQ-5D-5L states accounted for 90% of the respondents. The mean VAS value for the sample was 83.6 and the mean EQ-5D-5L index value was 0.95. Pain/discomfort was found to be the EQ-5D dimension with the highest prevalence of repor …
The 10 most commonly observed EQ-5D-5L states accounted for 90% of the respondents. The mean VAS value for the sample was 83.6 and th …
Toward a Smaller Design for EQ-5D-5L Valuation Studies.
Yang Z, Luo N, Oppe M, Bonsel G, Busschbach J, Stolk E. Yang Z, et al. Value Health. 2019 Nov;22(11):1295-1302. doi: 10.1016/j.jval.2019.06.008. Epub 2019 Aug 26. Value Health. 2019. PMID: 31708067 Free article.
BACKGROUND: To construct an EQ-5D-5L value set, the EuroQol Group developed a standard protocol named EuroQol Valuation Technology (EQ-VT), prescribing the valuation of 86 health states utilizing the composite time trade-off (cTTO) approach, and subsequently modeled the ob …
BACKGROUND: To construct an EQ-5D-5L value set, the EuroQol Group developed a standard protocol named EuroQol Valuation Technology (E …
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.
Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Janssen MF, et al. Qual Life Res. 2013 Sep;22(7):1717-27. doi: 10.1007/s11136-012-0322-4. Epub 2012 Nov 25. Qual Life Res. 2013. PMID: 23184421 Free PMC article.
PURPOSE: The aim of this study was to assess the measurement properties of the 5-level classification system of the EQ-5D (5L), in comparison with the 3-level EQ-5D (3L). METHODS: Participants (n = 3,919) from six countries, including eight patient groups with chron …
PURPOSE: The aim of this study was to assess the measurement properties of the 5-level classification system of the EQ-5D (5L), in co …
Unbiased Measure of General Quality of Life in Chronic Rhinosinusitis Reveals Disease Modifiers.
Epperson MV, McCann AC, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Epperson MV, et al. Laryngoscope. 2020 Oct 2. doi: 10.1002/lary.29139. Online ahead of print. Laryngoscope. 2020. PMID: 33006402
All patients completed a 22-item Sinonasal Outcome Test (SNOT-22)-from which nasal, sleep, ear/facial discomfort, and emotional subdomain scores were calculated, as well as the EQ-5D. Low EQ-5D VAS was defined as a score less than 80. RESULTS: On multi …
All patients completed a 22-item Sinonasal Outcome Test (SNOT-22)-from which nasal, sleep, ear/facial discomfort, and emotiona …
Responsiveness and minimal clinically important difference for the EQ-5D in chronic rhinosinusitis.
Hoehle LP, Phillips KM, Speth MM, Caradonna DS, Gray ST, Sedaghat AR. Hoehle LP, et al. Rhinology. 2019 Apr 1;57(2):110-116. doi: 10.4193/Rhin18.122. Rhinology. 2019. PMID: 30175337
METHODS: 203 adults undergoing medical management for CRS were prospectively recruited. General health-related QOL (using EQ-5D HUV and EQ-5D VAS) and CRS-specific QOL (using the 22-item Sinonasal Outcome Test [SNOT-22]) were measured at enrollment and …
METHODS: 203 adults undergoing medical management for CRS were prospectively recruited. General health-related QOL (using EQ-5D HUV a …
Quality of life impairment due to chronic rhinosinusitis in asthmatics is mediated by asthma control.
Phillips KM, Talat R, Caradonna DS, Gray ST, Sedaghat AR. Phillips KM, et al. Rhinology. 2019 Dec 1;57(6):430-435. doi: 10.4193/Rhin19.207. Rhinology. 2019. PMID: 31545327
A mediation model was created and validated to show that asthma control mediated the association between CRS symptom burden and decreased general health-related QOL. RESULTS: ACT score was associated with SNOT-22, EQ-5D VAS was associated with SNOT-22 score, …
A mediation model was created and validated to show that asthma control mediated the association between CRS symptom burden and decreased ge …
EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set.
Kreimeier S, Greiner W. Kreimeier S, et al. Value Health. 2019 Jan;22(1):31-37. doi: 10.1016/j.jval.2018.11.001. Value Health. 2019. PMID: 30661631 Free article. Review.
METHODS: This article brings together the experiences of the research team that developed and validated the EQ-5D-Y, supplemented by information derived from EQ-5D-Y study registrations on the EuroQol Group's website. ...This will support the development of a value …
METHODS: This article brings together the experiences of the research team that developed and validated the EQ-5D-Y, supplemented by …
3,737 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page